Navigation Links
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
Date:7/28/2014

IS-SC1 study.  Enrolled patient demographics and disease characteristics for the CHABLIS-SC1 study are consistent with our goal to enroll patients with higher levels of lupus activity and positive biomarkers despite the stable use of corticosteroids.  These characteristics appeared predictive of improved outcomes in our previous Phase 2 clinical study.  Additional information and publications from the CHABLIS-SC1 clinical study can be found at http://www.anthera.com/studies_chablis-sc1.htm.

We have submitted the final protocol to the US FDA for our second lupus registration study, CHABLIS-SC2. This second study is expected to enroll up to 400 patients with active lupus, including patients with glomerulonephritis who may have a previous diagnosis of Lupus Nephritis.  Consistent with the CHABLIS-SC1 clinical study, the primary endpoint of this second study will be the SRI-8 response. These two pivotal studies will form the basis of a submission for blisibimod as a treatment for patients with active lupus.

Blisibimod for the treatment of IgA Nephropathy (BRIGHT-SC)

The BRIGHT-SC clinical study is currently recruiting patients with a biopsy-proven diagnosis of IgA nephropathy in seven countries in Southeast Asia. We have begun expansion of the BRIGHT-SC study's footprint in Europe, Canada and Japan and expect to enroll patients in the new geographies in the fourth quarter of 2014.  It is our plan to conduct an interim analysis to determine the effect of blisibimod on proteinuria after eight weeks of treatment in the second half of 2014.

In April 2014, we met with Japan Pharmaceuticals and Medical Devices Agency ("PMDA") to discuss our registration program with blisibimod in patients with IgA nephropathy.  In this meeting we gained the PMDA's agreement on the acceptability of proteinuria as the primary efficacy endpoint to support marketing approval in
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
5. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
7. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
10. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
11. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015  Recognizing the unique position Massachusetts ... the most respected organizations in the New England medtech community, ... Industry Council (MassMEDIC), have partnered to celebrate the region,s ... Annual Massachusetts Medtech Week. This celebration will take place May ... Center in Boston . For more information ...
(Date:4/27/2015)... Mass. , April 27, 2015 ... a collaboration with Brainlab AG, a leading software-driven ... planning and surgical navigation. The collaboration provides patients ... Stimulation (DBS) therapy. DBS is intended to treat ... help reduce symptoms for movement disorders such as ...
(Date:4/27/2015)... , April 27, 2015  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced ... the United States Food and Drug Administration ("FDA") verifying ... in place following the warning letter it received from ... letter follows a re-inspection in March 2015 by the ...
Breaking Medicine Technology:First Annual Massachusetts Medtech Week Celebrated this May 2First Annual Massachusetts Medtech Week Celebrated this May 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 2Boston Scientific Announces Strategic Collaboration With Brainlab AG 3Boston Scientific Announces Strategic Collaboration With Brainlab AG 4CryoLife Announces Resolution of FDA Warning Letter 2
... Corporation , today announced that the U.S. Patent and ... which brings their total portfolio to 20 and bolsters ... wireless location systems (RTLS) for hospitals. (Logo: ... cover Awarepoint,s most accurate mesh-based location algorithm to date, ...
... opening ceremony for the world,s largest stem cell medical center ... ( www.rnl.co.kr ), South Korea,s premier adult stem cell firm ... in Beijing, China. Beijing RNL Stem Cell Medical Center is ... Li Hailing, www.yandaco.com ). Beijing RNL Stem Cell Medical ...
Cached Medicine Technology:Awarepoint Advances Industry Leadership with New Patented Technology 2RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2
(Date:4/27/2015)... MN (PRWEB) April 27, 2015 Based ... Secura Consultants is one of the few insurance marketing ... in the income and asset protection markets as well ... the industry has afforded Secura Consultants the opportunity to ... to make doing business easier and quicker. , An ...
(Date:4/27/2015)... Array Health , a leading provider of ... Hood, senior director of marketing, will participate in a ... Care Marketing Summit on April 29, 2015. The ... of Payer Services, Leavitt Partners, LLC, will address the ... retail/e-commerce perspective – and equip attendees with the insights ...
(Date:4/27/2015)... Thanks to a $7.5 million grant from ... institutions, including American University, will operate in a new ... behavioral research aimed at ending the AIDS epidemic. , ... HIV or AIDS, according to the latest statistics. At ... over the age of 13 was living with HIV, ...
(Date:4/27/2015)... Sitting or standing for long periods of ... and for those whose occupation requires them to be sitting ... drivers, or to be on their feet for most of ... be more severe and longer lasting. These people suffer from ... Revana of Northeast Houston Vein Center is offering tips on ...
(Date:4/27/2015)... OH (PRWEB) April 27, 2015 Douglas ... to help his clients feel secure, but also helps secure ... to 7 p.m., Douglas will be manning a booth at ... Center, Lausche Building, 717 E. 17th Ave., Columbus, Ohio. ... worthy event that will feature hundreds of adoptable pets from ...
Breaking Medicine News(10 mins):Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2
... three other scientists will receive The Gairdner International Awards, ... their exemplary// research on RNAs, cell motility and hormones. ... Toronto. ,John Dirks, president of the Gairdner ... our understanding of our cells with major ramifications for ...
... Fish oil has numerous health benefits and is being touted ... its honour is welcome.Nicolas G. Bazan, MD, PhD, Boyd Professor// ... LSU Health Sciences Centre in New Orleans, in a paper ... fish oil play in protecting cells in the retina from ...
... at the University of Illinois at Chicago in collaboration ... the structure of an enzyme in the virus that ... have detailed these findings in the March 27 issue ... hope that this could form a new drug target ...
... the effect of tiny nanoparticles on the health of ... traffic exhaust and are also used in making household ... The scientists will assess if these particles damage liver ... 80,000 times smaller than the width of a human ...
... the Vagisil Women's Health CenterSM conducted a survey on feminine ... women are taking active roles in their own feminine health ... aged 18 and older (63 percent) report that they go ... gynecologist, 61 percent say they "always" go for their annual ...
... overseas doctors in Britain are alarmed as new rules ... before they can work// in hospitals of the National ... doctors from the Indian subcontinent who could suddenly ... if there are no local doctors available the first preference ...
Cached Medicine News:Health News:Women aware of “feminine health” : their attitud 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: